Gate Crypto Flash News and Market Updates

Gate Flash News covers real-time crypto market updates, Bitcoin and Ethereum price movements, and key industry developments.
Today
00:30
0

Pump.fun Adjusts Reward Algorithm to Reduce Low-Quality Shilling Incentives

According to Odaily, Pump.fun co-founder Alon announced recently that the platform is adjusting its reward algorithm to reduce incentives for low-quality shilling behavior. The update aims to prevent users from earning rewards by recommending low-market-cap tokens without regard to follower profitability. Alon acknowledged that restricting rewards for micro-cap token recommendations may limit successful early-stage discoveries. The team is researching how to define quality early recommendations
More
PUMP-13.20%
00:29
0

Anthropic Researchers: Small Models Can Self-Replicate on IoT Devices; 9B Model Succeeds on 8 of 9 Hardware Types

According to Anthropic researchers William Zhou and Daniel Freeman, on October 12, small models may be capable of self-replicating on commercial IoT devices such as smart toasters within months. Tests showed a 9B model completed inference on 8 of 9 hardware types. Models of 30B and below can complete individual steps of replication but fail when combined end-to-end; GLM-5.2 and stronger models succeeded in end-to-end replication. In distributed testing on 15 budget Android TV boxes, Gemma4-26B r
More
GLM-5.05%
00:28
0

AI Film and TV Production Accelerates Toward Industrialization in 2026, Huatai Securities Reports

According to Huatai Securities research report on October 13, AI film and television production is advancing from single-point technology breakthroughs toward industrialized production, poised to reshape the global film and TV industry's cost structure and content supply model. Since 2026, domestic video models have shown continuous improvements in generation quality, inference efficiency, and usage costs, with AI-generated dramas and films entering distribution and release phases. Overseas stre
More
00:26
0

Sinova Pharma (06127) Stock Transfers HK$202M on October 12, Moves 315.73M Shares from HSBC

According to Hong Kong Exchanges and Clearing data released on October 12, Sinova Pharma (06127) experienced significant stock transfers with a total market value of HK$202 million, representing 5.43% of the company's shareholding. Shareholders transferred 302.68 million shares into Morgan Stanley Hong Kong Securities, while 315.73 million shares were transferred out from The Hongkong and Shanghai Banking Corporation.
00:23
0

DeepSeek Plans to Lead Seed Round in Robot AI Startup Winverse at $400M Valuation

According to Bloomberg, DeepSeek plans to lead a seed round investment in robot AI startup Winverse AI with tens of millions of dollars, valuing the company at approximately $400 million. Other committed investors include Long-Z Investments, a fund backed by Meituan. The deal remains pending, and valuation and investor details may change. Winverse was founded in 2026 by Hu Han, a former Tencent scientist who previously led Tencent's vision-language and embodied AI model team. Hu holds a doctorat
More
00:23
0

SanDisk Soars Over 3,000% Since February 2025 IPO, Leads S&P 500 on AI Datacenter Demand

According to Yahoo Finance, SanDisk (NASDAQ: SNDK) stock surged over 3,000% since its February 2025 IPO from Western Digital, reaching an intraday high of $1,479 on October 12 and pushing the company's market valuation above $200 billion. The sharp rally was driven by surging demand for NAND flash memory used in AI datacenters, as major tech firms expand infrastructure investments. SanDisk's datacenter business now accounts for approximately 25-33% of total revenue, with management projecting do
More
00:23
0

JPMorgan Upgrades Biogen to Overweight, Raises Price Target to $300 on October 12

According to CNBC, on October 12, JPMorgan upgraded Biogen's investment rating from Neutral to Overweight and raised its price target to $300 from $210. Analyst Chris Short cited a strengthened long-term growth outlook driven by strong clinical pipeline momentum through 2027, particularly highlighting Fezalamab, Olutasilatide, and Lecanemab cross-indication data as key catalysts. JPMorgan views Fezalamab, a candidate for rare kidney disease, as the strongest opportunity in Biogen's pipeline, wit
More
00:21
0

Standard Chartered Launches RLUSD Custody Services on October 12, Plans Collateral Integration With Ripple

According to Standard Chartered, the bank launched institutional custody services for RLUSD (Ripple USD), the dollar stablecoin issued on XRP Ledger, on October 12. The service is provided through the bank's Dubai International Financial Centre (DIFC) branch, regulated by the Dubai Financial Services Authority (DFSA), and targets qualified institutional clients. Standard Chartered is collaborating with Ripple and LMAX Group, a global financial trading platform operator, to implement a collateral
More
XRP-5.62%
00:21
0

Cambridge Technology (06166) Records HKD 1.935B in Deposits, 6.4432M Shares Pledged to Morgan Stanley Hong Kong on October 12

According to Hong Kong Stock Exchange filings and company announcement, on October 12, Cambridge Technology (06166) recorded a deposit transaction with total market value of HKD 1.935 billion, representing 19.91% of total shares. A shareholder deposited 6.4432 million shares with Morgan Stanley Hong Kong Securities, reducing shareholding by 1.98%. The company also announced the placement and issuance of 18.446 million H shares on October 12 pursuant to a placement agreement dated October 8, 2026
More
00:21
0

China Joyo Investment (01959) Deposits 48.6M Shares Worth HK$208M on Oct 12

According to Hong Kong Stock Exchange latest filing, on October 12, China Joyo Investment (01959) saw a deposit anomaly with total deposited market value reaching HK$208 million, representing 9.15% of total shares. A company shareholder deposited 48.66 million shares with Zhejiang Commercial International Finance, increasing its holding ratio by 9.18%.
00:21
0

Intellia Nominates ISM9546, Its 35th Preclinical Candidate for Autoimmune Diseases

Intellia (03696) announced today it has nominated ISM9546 as a preclinical candidate compound, a peripheral-restricted VAV1 molecular glue degrader for treating autoimmune diseases including inflammatory bowel disease (IBD) and rheumatoid arthritis (RA). The oral candidate demonstrated nanomolar-level potency in cellular assays and its peripheral-restricted properties aim to reduce central nervous system-related risks.
00:20
0

LaKE Pharma Completes 24-Week LAE102 Study, Initiates High-Dose Cohort

According to LaKE Pharma's announcement, the company recently completed a 24-week monotherapy study of LAE102 in the low-dose cohort, with consistent results from prior single-ascending-dose (SAD) and multiple-ascending-dose (MAD) studies. The low-dose group showed encouraging weight loss effects with observed increases in muscle mass and decreases in fat mass, while demonstrating good tolerability with no serious adverse events reported, and no cases of diarrhea, muscle cramps, or acne. The hig
More